Lina Nilsson, SVP at Recursion, discusses how generative AI is revolutionizing the medical field. She highlights innovative drug discovery techniques using CRISPR and machine learning, aimed at expediting therapies for genetic diseases. The conversation addresses the high costs and inefficiencies in drug development, advocating for data-driven methodologies. Lina also shares bold predictions about AI's potential to improve patient care and forecasts significant advancements in healthcare, including the possibility of extending human lifespans.
